Cargando…
Identification of Human IKK-2 Inhibitors of Natural Origin (Part I): Modeling of the IKK-2 Kinase Domain, Virtual Screening and Activity Assays
BACKGROUND: Their large scaffold diversity and properties, such as structural complexity and drug similarity, form the basis of claims that natural products are ideal starting points for drug design and development. Consequently, there has been great interest in determining whether such molecules sh...
Autores principales: | Sala, Esther, Guasch, Laura, Iwaszkiewicz, Justyna, Mulero, Miquel, Salvadó, Maria-Josepa, Pinent, Montserrat, Zoete, Vincent, Grosdidier, Aurélien, Garcia-Vallvé, Santiago, Michielin, Olivier, Pujadas, Gerard |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3044726/ https://www.ncbi.nlm.nih.gov/pubmed/21390216 http://dx.doi.org/10.1371/journal.pone.0016903 |
Ejemplares similares
-
Identification of PPARgamma Partial Agonists of Natural Origin (II): In Silico Prediction in Natural Extracts with Known Antidiabetic Activity
por: Guasch, Laura, et al.
Publicado: (2013) -
Identification of Novel Human Dipeptidyl Peptidase-IV Inhibitors of Natural Origin (Part I): Virtual Screening and Activity Assays
por: Guasch, Laura, et al.
Publicado: (2012) -
Identification of PPARgamma Partial Agonists of Natural Origin (I): Development of a Virtual Screening Procedure and In Vitro Validation
por: Guasch, Laura, et al.
Publicado: (2012) -
Identification of Novel Human Dipeptidyl Peptidase-IV Inhibitors of Natural Origin (Part II): In Silico Prediction in Antidiabetic Extracts
por: Guasch, Laura, et al.
Publicado: (2012) -
Docking, virtual high throughput screening and in silico fragment-based drug design
por: Zoete, Vincent, et al.
Publicado: (2009)